FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ILJIN, K.
Right arrow Articles by ALITALO, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ILJIN, K.
Right arrow Articles by ALITALO, K.
(The FASEB Journal. 1999;13:377-386.)
© 1999 FASEB


RESEARCH COMMUNICATION

Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter

KRISTIINA ILJINa , ANTOINISE DUBEb , SIRPA KONTUSAARIc , JAANA KORHONENa , ISTO LAHTINENa , PETER OETTGENb and KARI ALITALOa


a Molecular/Cancer Biology Laboratory, Haartman Institute and Department of Biomedicine, University of Helsinki, Helsinki, Finland;

b NEB Bone and Joint Institute, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, Boston, Massachusetts 02115, USA; and

c Biocenter Oulu and Department of Biochemistry, University of Oulu, Linnanmaa, 90570 Oulu, Finland

The Tie gene encodes an endothelial cell receptor tyrosine kinase necessary for normal vascular development. The Tie gene promoter targets expression of heterologous genes specifically to endothelial cells in transgenic mice. Here we have characterized the promoter sequences critical for endothelial cell-specific activity in cultured cells and transgenic mice. Progressive deletions and site-directed mutations of the promoter showed that the critical endothelial cell-specific elements are an octamer transcription factor binding site and several Ets binding sites located in two clusters within 300 bp upstream of the major transcription initiation site. Among members of the Ets transcription factor family tested, NERF-2 (a novel transcription factor related to the ets factor ELF-1), which is expressed in endothelial cells, and ETS2 showed the strongest transactivation of the Tie promoter; ETS1 gave lower levels of stimulation and the other Ets factors gave little or no transactivation. Furthermore, the Tie promoter directed the production of high amounts of human growth hormone into the circulation of transgenic mice. The secreted amounts correlated with transgene copy number, being relatively insensitive to the effects of the transgene integration site. These properties suggest that Tie promoter activity is controlled by endothelial cell Ets factors and that it has potential for use in vectors for endothelial cell-specific gene expression.—Iljin, K., Dube, A., Kontusaari, S., Korhonen, J., Lahtinen, I., Oettgen, P., Alitalo, K. Role of Ets factors in the activity and endothelial cell specificity of the mouse Tie gene promoter.


Key Words: gene therapy • receptor tyrosine kinase • vascular endothelium




This article has been cited by other articles:


Home page
BloodHome page
Y. Okada, E. Jin, V. Nikolova-Krstevski, K. Yano, J. Liu, D. Beeler, K. Spokes, M. Kitayama, N. Funahashi, T. Doi, et al.
A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo
Blood, September 15, 2008; 112(6): 2336 - 2339.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Okada, K. Yano, E. Jin, N. Funahashi, M. Kitayama, T. Doi, K. Spokes, D. L. Beeler, S.-C. Shih, H. Okada, et al.
A Three-Kilobase Fragment of the Human Robo4 Promoter Directs Cell Type-Specific Expression in Endothelium
Circ. Res., June 22, 2007; 100(12): 1712 - 1722.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Oettgen
Regulation of Vascular Inflammation and Remodeling by ETS Factors
Circ. Res., November 24, 2006; 99(11): 1159 - 1166.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Huang, C. Brown, W. Ni, E. Maynard, A. C. Rigby, and P. Oettgen
Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis
Blood, April 15, 2006; 107(8): 3153 - 3160.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Hegen, S. Koidl, K. Weindel, D. Marme, H. G. Augustin, and U. Fiedler
Expression of Angiopoietin-2 in Endothelial Cells Is Controlled by Positive and Negative Regulatory Promoter Elements
Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1803 - 1809.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X. Wang, Y. Peng, Y. Ma, and N. Jahroudi
Histone H1-like protein participates in endothelial cell-specific activation of the von Willebrand factor promoter
Blood, September 15, 2004; 104(6): 1725 - 1732.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Minami, J. A. Kuivenhoven, V. Evans, T. Kodama, R. D. Rosenberg, and W. C. Aird
Ets Motifs Are Necessary for Endothelial Cell-Specific Expression of a 723-bp Tie-2 Promoter/Enhancer in Hprt Targeted Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 2041 - 2047.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y.-H. Cheng and S. Handwerger
Identification of an Enhancer of the Human Activating Protein-2{alpha} Gene That Contains a Critical Ets1 Binding Site
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3305 - 3311.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Peng and N. Jahroudi
The NFY Transcription Factor Inhibits von Willebrand Factor Promoter Activation in Non-endothelial Cells through Recruitment of Histone Deacetylases
J. Biol. Chem., February 28, 2003; 278(10): 8385 - 8394.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Elvert, A. Kappel, R. Heidenreich, U. Englmeier, S. Lanz, T. Acker, M. Rauter, K. Plate, M. Sieweke, G. Breier, et al.
Cooperative Interaction of Hypoxia-inducible Factor-2alpha (HIF-2alpha ) and Ets-1 in the Transcriptional Activation of Vascular Endothelial Growth Factor Receptor-2 (Flk-1)
J. Biol. Chem., February 21, 2003; 278(9): 7520 - 7530.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. ILJIN, T. V. PETROVA, T. VEIKKOLA, V. KUMAR, M. POUTANEN, and K. ALITALO
A fluorescent Tie1 reporter allows monitoring of vascular development and endothelial cell isolation from transgenic mouse embryos
FASEB J, November 1, 2002; 16(13): 1764 - 1774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Hadri, A. Ozog, F. Soncin, and A.-M. Lompre
Basal Transcription of the Mouse Sarco(endo)plasmic Reticulum Ca2+-ATPase Type 3 Gene in Endothelial Cells Is Controlled by Ets-1 and Sp1
J. Biol. Chem., September 20, 2002; 277(39): 36471 - 36478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Lelievre, F. Lionneton, V. Mattot, N. Spruyt, and F. Soncin
Ets-1 Regulates fli-1 Expression in Endothelial Cells. IDENTIFICATION OF ETS BINDING SITES IN THE fli-1 GENE PROMOTER
J. Biol. Chem., July 5, 2002; 277(28): 25143 - 25151.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Gaspar, S. Thai, C. Voland, A. Dube, T. A. Libermann, M.L. Iruela-Arispe, and P. Oettgen
Opposing Functions of the Ets Factors NERF and ELF-1 During Chicken Blood Vessel Development
Arterioscler. Thromb. Vasc. Biol., July 1, 2002; 22(7): 1106 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Marchetti, C. Gimond, K. Iljin, C. Bourcier, K. Alitalo, J. Pouyssegur, and G. Pages
Endothelial cells genetically selected from differentiating mouse embryonic stem cells incorporate at sites of neovascularization in vivo
J. Cell Sci., May 15, 2002; 115(10): 2075 - 2085.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Oettgen
Transcriptional Regulation of Vascular Development
Circ. Res., August 31, 2001; 89(5): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. ILJIN, M. J. KARKKAINEN, E. C. LAWRENCE, M. A. KIMAK, M. UUTELA, J. TAIPALE KATRI PAJUSOLA LEENA ALHONEN, M. HALMEKYTO, D. N. FINEGOLD, R. E. FERRELL, and K. ALITALO
VEGFR3 gene structure, regulatory region, and sequence polymorphisms
FASEB J, April 1, 2001; 15(6): 1028 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Etoh, H. Inoue, S. Tanaka, G. F. Barnard, S. Kitano, and M. Mori
Angiopoietin-2 Is Related to Tumor Angiogenesis in Gastric Carcinoma: Possible in Vivo Regulation via Induction of Proteases
Cancer Res., March 1, 2001; 61(5): 2145 - 2153.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. Dube, S. Thai, J. Gaspar, S. Rudders, T. A. Libermann, L. Iruela-Arispe, and P. Oettgen
ELF-1 Is a Transcriptional Regulator of the Tie2 Gene During Vascular Development
Circ. Res., February 2, 2001; 88(2): 237 - 244.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Ishikawa, S. Baba, T. Katsuya, N. Iwai, T. Asai, M. Fukuda, S. Takiuchi, Y. Fu, T. Mannami, J. Ogata, et al.
T+31C Polymorphism of Angiotensinogen Gene and Essential Hypertension
Hypertension, February 1, 2001; 37(2): 281 - 285.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E Gustafsson, C Brakebusch, K Hietanen, and R Fassler
Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice
J. Cell Sci., January 2, 2001; 114(4): 671 - 676.
[Abstract] [PDF]


Home page
BloodHome page
A. Kappel, T. M. Schlaeger, I. Flamme, S. H. Orkin, W. Risau, and G. Breier
Role of SCL/Tal-1, GATA, and Ets transcription factor binding sites for the regulation of Flk-1 expression during murine vascular development
Blood, November 1, 2000; 96(9): 3078 - 3085.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The Federation of American Societies for Experimental Biology.